Browse the full record of transactions filed by 박창원, Vice-Président. Director active across 2 companies, notably 카나프테라퓨틱스. In total, 17,943 filings have been recorded. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Park Chang-won is Vice President at 카나프테라퓨틱스, a company specializing in biotechnology. He plays a key role in managing operations and defining the company's strategies. His technical expertise is essential for the success of 카나프테라퓨틱스.